Moderna, Inc. (MRNA)

Moderna Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2,907	3,205	6,848	2,624	236.91
Short-Term Investments	5,697	6,697	3,879	1,984	867.12
Cash & Cash Equivalents	8,604	9,902	10,727	4,608	1,104
Cash Growth	-13.11%	-7.69%	132.79%	317.38%	-27.46%
Receivables	892	1,385	3,175	1,391	5.37
Inventory	202	949	1,441	47	0
Other Current Assets	627	1,195	728	252	19.4
Total Current Assets	10,325	13,431	16,071	6,298	1,129
Property, Plant & Equipment	2,658	2,139	1,383	387	287.91
Long-Term Investments	4,677	8,318	6,843	650	170.78
Other Long-Term Assets	766	1,970	372	2	1.93
Total Long-Term Assets	8,101	12,427	8,598	1,039	460.62
Total Assets	18,426	25,858	24,669	7,337	1,589
Accounts Payable	520	487	302	18	7.09
Deferred Revenue	651	2,711	6,868	4,044	202.31
Other Current Liabilities	1,844	1,725	1,958	327	-66.28
Total Current Liabilities	3,015	4,923	9,128	4,389	143.12
Long-Term Debt	1,218	1,004	705	207	132.36
Other Long-Term Liabilities	339	808	691	180	139.13
Total Long-Term Liabilities	1,557	1,812	1,396	387	271.5
Total Liabilities	4,572	6,735	10,524	4,776	414.61
Total Debt	1,218	1,004	705	207	132.36
Debt Growth	21.31%	42.41%	240.58%	56.39%	295.25%
Retained Earnings	13,606	18,320	9,958	-2,244	-1,496.45
Comprehensive Income	-123	-370	-24	3	1.8
Shareholders' Equity	13,854	19,123	14,145	2,561	1,175
Net Cash / Debt	7,386	8,898	10,022	4,401	971.67
Net Cash / Debt Growth	-16.99%	-11.22%	127.72%	352.93%	-34.72%
Net Cash Per Share	19.34	21.39	23.25	11.55	2.94
Working Capital	7,310	8,508	6,943	1,909	985.69
Book Value Per Share	36.27	48.54	35.10	6.72	3.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).